E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/16/2009 in the Prospect News Special Situations Daily.

Hawk investor Gamco wants company to rescind poison pill

By Lisa Kerner

Charlotte, N.C., March 16 - Gamco Asset Management Inc. said it will propose at Hawk Corp.'s annual meeting that the company's board of directors either redeem the preferred share purchase rights issued under the Jan. 4, 2008 rights agreement or submit the issue to a shareholder vote.

The investor made its request in a March 16 letter to Hawk's board and included in a schedule 13D/A filed on Monday with the Securities and Exchange Commission.

Gamco owns 9.87% of the Cleveland friction products manufacturer's outstanding stock.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.